REQUEST A DEMO
Total
USD $0.00
Search more companies

Eywa Pharma Private Limited (India)

Main Activities: Other Business Support Services
Full name: Eywa Pharma Private Limited Profile Updated: March 06, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Eywa Pharma Private Limited is a company in India, with a head office in Kanchipuram. The enterprise operates in the Other Business Support Services industry. It was incorporated on April 27, 2015. 10 (2025) employees currently work for Eywa Pharma Private Limited. In 2025, the company reported a net sales revenue drop of 28.74%. Its’ total assets recorded a negative growth of 5.22%. In, 2025, the company’s net profit margin increased by 337.72%.

Legal Address
Door No.5/A5, Third Cross Road,Sipcot It Park,Siruseri
Kanchipuram; Tamil Nadu; Postal Code: 603103

Contact Details: Purchase the Eywa Pharma Private Limited report to view the information.

Website: http://www.eywapharma.com

Basic Information
Total Employees:
Purchase the Eywa Pharma Private Limited report to view the information.
Registered Capital:
Purchase the Eywa Pharma Private Limited report to view the information.
Financial Auditors:
Purchase the Eywa Pharma Private Limited report to view the information.
Incorporation Date:
April 27, 2015
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Whole Time Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Eywa Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-28.74%
Total operating revenue
-22.78%
Operating Profit/Loss (EBIT)
58.12%
EBITDA
66.7%
Net Profit/Loss for the Period
56.58%
Total Assets
-5.22%
Total Equity
-12.17%
Operating Profit Margin (ROS)
351.45%
Net Profit Margin
337.72%
Return on Equity (ROE)
14.17%
Debt/Equity
16.32%
Quick Ratio
-0.69%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?